Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
This report contains market size and forecasts of Plasma-derived Therapies in Global, including the following market information:
Global Plasma-derived Therapies Market Size 2024-2030, ($ millions)
The global Plasma-derived Therapies market is projected to reach US$ million by 2029.
We surveyed the Plasma-derived Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasma-derived Therapies Market, by Type, 2024-2030 ($ millions)
Global Plasma-derived Therapies Market Segment Percentages, by Type
Albumin
Immunoglobulin
Factor VIII
Others
Global Plasma-derived Therapies Market, by Application, 2024-2030 ($ millions)
Global Plasma-derived Therapies Market Segment Percentages, by Application
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Global Plasma-derived Therapies Market, By Region and Country, 2024-2030 ($ Millions)
Global Plasma-derived Therapies Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Plasma-derived Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Plasma-derived Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Plasma-derived Therapies Overall Market Size
2.1 Global Plasma-derived Therapies Market Size: 2023 VS 2030
2.2 Global Plasma-derived Therapies Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Plasma-derived Therapies Players in Global Market
3.2 Global Companies Plasma-derived Therapies Product & Technology
4 Plasma-derived Therapies Companies Profiles
4.1 CSL Behring LLC
4.1.1 CSL Behring LLC Company Summary
4.1.2 CSL Behring LLC Business Overview
4.1.3 CSL Behring LLC Plasma-derived Therapies Product Offerings & Technology
4.1.4 CSL Behring LLC Plasma-derived Therapies R&D, and Plans
4.2 Shire
4.2.1 Shire Company Summary
4.2.2 Shire Business Overview
4.2.3 Shire Plasma-derived Therapies Product Offerings & Technology
4.2.4 Shire Plasma-derived Therapies R&D, and Plans
4.3 Bayer
4.3.1 Bayer Company Summary
4.3.2 Bayer Business Overview
4.3.3 Bayer Plasma-derived Therapies Product Offerings & Technology
4.3.4 Bayer Plasma-derived Therapies R&D, and Plans
4.4 Kedrion
4.4.1 Kedrion Company Summary
4.4.2 Kedrion Business Overview
4.4.3 Kedrion Plasma-derived Therapies Product Offerings & Technology
4.4.4 Kedrion Plasma-derived Therapies R&D, and Plans
4.5 Takeda
4.5.1 Takeda Company Summary
4.5.2 Takeda Business Overview
4.5.3 Takeda Plasma-derived Therapies Product Offerings & Technology
4.5.4 Takeda Plasma-derived Therapies R&D, and Plans
4.6 Biotest
4.6.1 Biotest Company Summary
4.6.2 Biotest Business Overview
4.6.3 Biotest Plasma-derived Therapies Product Offerings & Technology
4.6.4 Biotest Plasma-derived Therapies R&D, and Plans
4.7 Octaparma
4.7.1 Octaparma Company Summary
4.7.2 Octaparma Business Overview
4.7.3 Octaparma Plasma-derived Therapies Product Offerings & Technology
4.7.4 Octaparma Plasma-derived Therapies R&D, and Plans
4.8 Bio Products Laboratory (BPL)
4.8.1 Bio Products Laboratory (BPL) Company Summary
4.8.2 Bio Products Laboratory (BPL) Business Overview
4.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offerings & Technology
4.8.4 Bio Products Laboratory (BPL) Plasma-derived Therapies R&D, and Plans
4.9 LFB
4.9.1 LFB Company Summary
4.9.2 LFB Business Overview
4.9.3 LFB Plasma-derived Therapies Product Offerings & Technology
4.9.4 LFB Plasma-derived Therapies R&D, and Plans
4.10 Grifols
4.10.1 Grifols Company Summary
4.10.2 Grifols Business Overview
4.10.3 Grifols Plasma-derived Therapies Product Offerings & Technology
4.10.4 Grifols Plasma-derived Therapies R&D, and Plans
5 Sights by Region
5.1 By Region - Global Plasma-derived Therapies Market Size, 2024 & 2030
5.2 By Region - Global Plasma-derived Therapies Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of Plasma-derived Therapies in United States
5.3.2 United States Plasma-derived Therapies Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Plasma-derived Therapies in Europe
5.4.2 Europe Plasma-derived Therapies Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Plasma-derived Therapies in China
5.5.2 China Plasma-derived Therapies Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Plasma-derived Therapies Market Size Markets, 2024 & 2030
6.2 Albumin
6.3 Immunoglobulin
6.4 Factor VIII
6.5 Others
7 Sights by Application
7.1 By Application - Global Plasma-derived Therapies Market Size, 2024 & 2030
7.2 Hemophilia
7.3 Primary Immunodeficiencies (PIDs)
7.4 Idiopathic Thrombocytopenic Purpura (ITP)
7.5 COVID-19
7.6 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Plasma-derived Therapies Market Opportunities & Trends in Global Market
Table 2. Plasma-derived Therapies Market Drivers in Global Market
Table 3. Plasma-derived Therapies Market Restraints in Global Market
Table 4. Key Players of Plasma-derived Therapies in Global Market
Table 5. Global Companies Plasma-derived Therapies Product & Technology
Table 6. CSL Behring LLC Company Summary
Table 7. CSL Behring LLC Plasma-derived Therapies Product Offerings
Table 8. Shire Company Summary
Table 9. Shire Plasma-derived Therapies Product Offerings
Table 10. Bayer Company Summary
Table 11. Bayer Plasma-derived Therapies Product Offerings
Table 12. Kedrion Company Summary
Table 13. Kedrion Plasma-derived Therapies Product Offerings
Table 14. Takeda Company Summary
Table 15. Takeda Plasma-derived Therapies Product Offerings
Table 16. Biotest Company Summary
Table 17. Biotest Plasma-derived Therapies Product Offerings
Table 18. Octaparma Company Summary
Table 19. Octaparma Plasma-derived Therapies Product Offerings
Table 20. Bio Products Laboratory (BPL) Company Summary
Table 21. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offerings
Table 22. LFB Company Summary
Table 23. LFB Plasma-derived Therapies Product Offerings
Table 24. Grifols Company Summary
Table 25. Grifols Plasma-derived Therapies Product Offerings
Table 26. By Region? Global Plasma-derived Therapies Revenue, (US$, Mn), 2024 & 2030
Table 27. By Region - Global Plasma-derived Therapies Revenue, (US$, Mn), 2024-2030
Table 28. By Type ? Global Plasma-derived Therapies Market Size, (US$, Mn), 2024 & 2030
Table 29. By Application? Global Plasma-derived Therapies Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. Plasma-derived Therapies Segment by Type in 2030
Figure 2. Plasma-derived Therapies Segment by Application in 2030
Figure 3. Global Plasma-derived Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Plasma-derived Therapies Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Plasma-derived Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Plasma-derived Therapies Revenue Market Share, 2024-2030
Figure 8. By Type - Global Plasma-derived Therapies Revenue Market Share, 2024-2030
Figure 9. By Application - Global Plasma-derived Therapies Revenue Market Share, 2024-2030
